Elevated WBC and Platelet Count with Otherwise Normal CBC
The most common causes of isolated leukocytosis with thrombocytosis are reactive/secondary processes including infection, inflammation, tissue damage, and metabolic conditions—not primary hematologic malignancies.
Primary Differential Diagnosis
Reactive/Secondary Causes (Most Common)
Infection and Inflammation are the predominant causes. Common hematological abnormalities in inflammatory conditions include leukocytosis (often with neutrophilia) and reactive thrombocytosis 1. In Adult-Onset Still's Disease (AOSD), for example, 50% of patients have WBC counts >15×10⁹/L, with 37% exceeding 20×10⁹/L, accompanied by reactive thrombocytosis 1.
Key reactive causes include:
- Acute infection (bacterial infections most commonly cause neutrophilic leukocytosis with elevated platelets) 2, 3
- Chronic inflammatory conditions (AOSD, rheumatologic diseases) 1
- Tissue damage/trauma (surgery, burns, myocardial infarction) 4
- Metabolic syndrome/obesity (platelet and WBC counts are significantly elevated in metabolic syndrome patients) 5
- Medications (corticosteroids, growth factors) 6, 7
- Smoking 4
- Post-splenectomy state (physiologic elevation of both WBC and platelets) 8
Myeloproliferative Neoplasms (Less Common but Critical to Exclude)
Essential Thrombocythemia (ET) presents with platelet count ≥450×10⁹/L, though leukocytosis is not a defining feature 9, 10. Progressive leukocytosis in ET warrants escalation to high-risk management 10.
Chronic Myeloid Leukemia (CML) characteristically shows leukocytosis with left-shifted granulopoiesis and often thrombocytosis 11. The WBC count can be markedly elevated, and platelet counts may be normal or increased 11.
Polycythemia Vera (PV) and Primary Myelofibrosis (PMF) can present with leukocytosis and thrombocytosis, though hemoglobin elevation (PV) or anemia with bone marrow fibrosis (PMF) are typically present 9, 12.
Clinical Approach Algorithm
Step 1: Assess Clinical Context
- Acute symptoms (fever, pain, recent surgery/trauma) → strongly suggests reactive process 2, 4
- Chronic symptoms (weight loss, night sweats, splenomegaly, pruritus) → raises concern for myeloproliferative neoplasm 11, 9
- Medication review (corticosteroids, G-CSF) 6, 7
Step 2: Examine Peripheral Blood Smear
This is mandatory to evaluate:
- White cell differential and maturity (left shift suggests infection or CML) 11, 2
- Platelet morphology (giant platelets suggest inherited thrombocytopenia; small mature platelets in ET) 9, 13
- Presence of immature cells or dysplasia 11
Step 3: Quantify the Elevation
Degree of leukocytosis:
- WBC 10-15×10⁹/L: Most commonly reactive 2, 7
- WBC >15×10⁹/L with band forms ≥6%: High probability of bacterial infection 2
- WBC >20×10⁹/L: Consider both severe infection and hematologic malignancy 1
Degree of thrombocytosis:
- Platelets 450-1000×10⁹/L: Both reactive and clonal causes possible 9, 14
- Platelets >1000×10⁹/L: 66.6% are secondary/reactive, 33.4% are clonal (mostly myeloproliferative disorders) 14
Step 4: Additional Laboratory Testing
If infection/inflammation suspected:
- CRP, ESR (elevated in inflammatory conditions) 1
- Blood cultures if febrile 2
- Urinalysis if UTI suspected 2
If myeloproliferative neoplasm suspected:
- JAK2 V617F mutation (present in ~95% of PV, ~60% of ET and PMF) 9, 12
- BCR-ABL1 testing (RT-PCR or FISH for CML) 11
- CALR and MPL mutations (in JAK2-negative ET/PMF) 9
- Bone marrow biopsy if molecular testing positive or high clinical suspicion 11, 9
Critical Pitfalls to Avoid
Do not dismiss leukocytosis as "stress response" without excluding infection 2. An elevated WBC count (≥14,000 cells/mm³) or left shift (≥6% bands) warrants careful assessment for bacterial infection 2.
Extreme thrombocytosis (>1000×10⁹/L) is NOT always malignant—two-thirds are reactive 14. However, clonal thrombocytosis carries higher bleeding/thrombotic risk (17.1% vs 7.9%) 14.
Normal hemoglobin does not exclude myeloproliferative neoplasm. ET and early-stage CML can present with isolated leukocytosis and thrombocytosis 11, 9.
Age and comorbidities affect "normal" WBC ranges. In hospitalized patients without infection/malignancy, the reference range extends to 14.5×10⁹/L 7. Age, race, BMI, diabetes, CKD, COPD, and steroid use all elevate baseline WBC 7.
Platelet-to-WBC ratio may provide prognostic information. A ratio <20 is associated with infection in post-splenectomy patients 8 and adverse outcomes in acute inflammatory conditions 15.
When to Refer to Hematology
Immediate referral if:
- Peripheral smear shows immature cells, dysplasia, or left-shifted myeloid maturation 11
- Constitutional symptoms (fever, weight loss, night sweats) with persistent cytopenias 11, 9
- Splenomegaly on examination 11, 9
Urgent referral if: